- Upregulated Long Noncoding RNA LINC01234 Predicts Unfavorable Prognosis for Colorectal Cancer and Negatively Correlates With KLF6 Expression
-
Jiang X, Zhu Q, Wu P, Zhou F, Chen J
- KMID: 2460913
- Ann Lab Med.
- 2020 Mar;40(2):155-163.
- doi: 10.3343/alm.2020.40.2.155
BACKGROUND: LINC01234, a long noncoding RNA (lncRNA), is overexpressed in several cancers, including colorectal cancer (CRC). We investigated the role of LINC01234 in CRC development and confirmed its correlation with... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Sodium Cromoglycate on Acetic Acid-induced Ulcerative Colitis in Mice
-
Ghafouri Z, Seyyedian , Nikbakht J, Kouhsari E, Bayat S, Zargar H, Houshmand
- KMID: 2471138
- Korean J Gastroenterol.
- 2020 Jan;75(1):39-45.
- doi: 10.4166/kjg.2020.75.1.39
BACKGROUND/AIMS: Ulcerative colitis (UC) is a type of inflammatory bowel disease that mainly involves the colon. Thus far, glucocorticoids and amino-salicylate have been the main treatment. METHODS: To assess drugs with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
-
Kim J, Im JP, Yim JJ, Lee CK, Park DI, Eun CS, Jung SA, Shin JE, Lee KM, Cheon JH
- KMID: 2471137
- Korean J Gastroenterol.
- 2020 Jan;75(1):29-38.
- doi: 10.4166/kjg.2020.75.1.29
BACKGROUND/AIMS: Anti-tumor necrosis factor (TNF) therapy is used widely for the treatment of inflammatory bowel disease (IBD). In the present study, the characteristics and outcomes of tuberculosis (TB) in IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
-
Jung Y
- KMID: 2471132
- Korean J Gastroenterol.
- 2020 Jan;75(1):1-3.
- doi: 10.4166/kjg.2020.75.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts
-
Kang B, Kim JE, Jung JH, Choe JY, Kim MJ, Choe YH, Kim S, Koh H, Lee YM, Lee JH, Lee Y, Lee JH, Lee HJ, Jang HJ, Choi Y, Choi SY, Kim JY, Choe BH
- KMID: 2467893
- Pediatr Gastroenterol Hepatol Nutr.
- 2020 Jan;23(1):49-62.
- doi: 10.5223/pghn.2020.23.1.49
PURPOSE: We aimed to investigate the disease phenotype of Korean pediatric Crohn's disease (CD) patients at diagnosis according to the Paris classification by comparison with patients from the European multicenter... -
- CITED
-
- Close
- SHARE
-
- Close
- Knowledge and Viewpoints on Biosimilar Monoclonal Antibodies among Asian Physicians: Comparison with European Physicians
-
Park SK, Moon W, Kim ES, Park SH, Park DI
- KMID: 2469908
- Korean J Gastroenterol.
- 2019 Dec;74(6):333-340.
- doi: 10.4166/kjg.2019.74.6.333
BACKGROUND/AIMS: Current knowledge and viewpoints regarding biosimilars among physicians in Asia are unknown, even though these were investigated by European Crohn's and Colitis Organization (ECCO) members in 2013 and 2015.... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Physician's Perspectives on Biosimilars in Inflammatory Bowel Disease: Are We Ready to Use?
-
Na SY
- KMID: 2469903
- Korean J Gastroenterol.
- 2019 Dec;74(6):301-303.
- doi: 10.4166/kjg.2019.74.6.301
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Immunosuppressive Effect of Exosomes from Mesenchymal Stromal Cells in Defined Medium on Experimental Colitis
-
Ma ZJ, Wang YH, Li ZG, Wang Y, Li BY, Kang HY, Wu XY
- KMID: 2465884
- Int J Stem Cells.
- 2019 Nov;12(3):440-448.
- doi: 10.15283/ijsc18139
BACKGROUND AND OBJECTIVES: The exosomes released by mesenchymal stromal cells (MSCs) in classical FBS-containing media have been demonstrated as an alternative, cell-free therapy in various diseases including inflammatory bowel disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
-
Na SY, Moon W
- KMID: 2464308
- Gut Liver.
- 2019 Nov;13(6):604-616.
- doi: 10.5009/gnl19019
New therapeutic strategies in inflammatory bowel disease (IBD) have shifted from symptom control towards treat-to-target algorithms in order to optimize treatment results. The treatment of IBD has evolved with the... -
- CITED
-
- Close
- SHARE
-
- Close
- Quality of information on the Internet for Korean patients with inflammatory bowel disease
-
Yoon JS, Lee SJ, Kim ES, Kim SK, Jung MK, Lee HS, Kwon YH, Nam SY, Jeon SW, Jin S, Lee JS, Yeo SJ
- KMID: 2463479
- Korean J Intern Med.
- 2019 Nov;34(6):1215-1222.
- doi: 10.3904/kjim.2018.019
BACKGROUND/AIMS: The Internet is the main resource for health-related information. The incidence of inflammatory bowel disease (IBD) is rapidly increasing in Asian countries. However, the quality of websites for IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Burden of Psychiatric Disorders among Pediatric and Young Adults with Inflammatory Bowel Disease: A Population-Based Analysis
-
Thavamani , Umapathi K, Khatana J, Gulati R
- KMID: 2462092
- Pediatr Gastroenterol Hepatol Nutr.
- 2019 Nov;22(6):527-535.
- doi: 10.5223/pghn.2019.22.6.527
PURPOSE: There is increasing prevalence of psychiatric disorders among inflammatory bowel Disease (IBD) population. Further, presence of psychiatric disorders has been shown as an independent predictor of quality of life... -
- CITED
-
- Close
- SHARE
-
- Close
- Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice
-
Nakagawa T, Kobayashi , Nishikawa , Yamada F, Asai S, Sameshima , Suzuki Y, Watanabe M, Hibi T
- KMID: 2465816
- Intest Res.
- 2019 Oct;17(4):504-515.
- doi: 10.5217/ir.2019.00030
BACKGROUND/AIMS: An interim analysis of post-marketing surveillance of CT-P13, an infliximab biosimilar, was performed to evaluate its safety and efficacy in Japanese patients with inflammatory bowel disease. METHODS: Patients were prospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior
-
Banerjee R, Pal P, Hutfless S, Ganesh BG, Reddy DN
- KMID: 2465814
- Intest Res.
- 2019 Oct;17(4):486-495.
- doi: 10.5217/ir.2018.00174
BACKGROUND/AIMS: Information about familial aggregation of inflammatory bowel disease (IBD) in Asia is limited. We aimed to analyze the prevalence and risk of familial IBD in an Indian cohort and... -
- CITED
-
- Close
- SHARE
-
- Close
- Nutritional approach as therapeutic manipulation in inflammatory bowel disease
-
Yoon JY
- KMID: 2465812
- Intest Res.
- 2019 Oct;17(4):463-475.
- doi: 10.5217/ir.2019.00078
Malnutrition is observed more frequently in patients with inflammatory bowel disease (IBD) than in the general population and associated with adverse clinical outcomes. This study aimed to review the current... -
- CITED
-
- Close
- SHARE
-
- Close
- Importance of nutritional therapy in the management of intestinal diseases: beyond energy and nutrient supply
-
Kim SE
- KMID: 2465810
- Intest Res.
- 2019 Oct;17(4):443-454.
- doi: 10.5217/ir.2019.00075
The gut is an immune-microbiome-epithelial complex. Gut microbiome-host interactions have widespread biological implications, and the role of this complex system extends beyond the digestion of food and nutrient absorption. Dietary... -
- CITED
-
- Close
- SHARE
-
- Close
- Is Indefinite Dysplasia a Risk Factor for Advanced Colorectal Neoplasia in Patients with Inflammatory Bowel Disease?
-
Park JJ
- KMID: 2460991
- Korean J Gastroenterol.
- 2019 Oct;74(4):242-244.
- doi: 10.4166/kjg.2019.74.4.242
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Sex-related Alterations of Gut Microbiota in the C57BL/6 Mouse Model of Inflammatory Bowel Disease
-
Son HJ, Kim N, Song CH, Nam RH, Choi SI, Kim JS, Lee DH
- KMID: 2468799
- J Cancer Prev.
- 2019 Sep;24(3):173-182.
- doi: 10.15430/JCP.2019.24.3.173
BACKGROUND: Gut microbiota is closely associated with development and exacerbation of inflammatory bowel diseases (IBD). The aim of this study was to investigate differences in gut microbiota depending on sex... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidrug-resistant Disseminated Tuberculosis Related to Infliximab in a Patient with Ulcerative Colitis and Negative Evaluation for Latent Tuberculosis
-
Jun YK, Chun J, Kang EA, Lee HJ, Im JP, Kim JS
- KMID: 2458698
- Korean J Gastroenterol.
- 2019 Sep;74(3):168-174.
- doi: 10.4166/kjg.2019.74.3.168
Anti-tumor necrosis factor (anti-TNF) is an effective biological agent for the treatment of moderate-to-severe active ulcerative colitis (UC) refractory to conventional therapy. On the other hand, anti-TNF therapy is strongly... -
- CITED
-
- Close
- SHARE
-
- Close
- Inflammatory Bowel Disease and the Risk of Herpes Zoster
-
Lai SW
- KMID: 2458516
- Gut Liver.
- 2019 Sep;13(5):582-582.
- doi: 10.5009/gnl19141
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
-
Choi SY, Kang B, Choe YH
- KMID: 2458511
- Gut Liver.
- 2019 Sep;13(5):541-548.
- doi: 10.5009/gnl18129
BACKGROUND/AIMS: Infliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response... -
- CITED
-
- Close
- SHARE
-
- Close
